Vocabria

Vocabria (cabotegravir) is an antiretroviral medication used for HIV treatment and prevention. Administered as an intramuscular injection, it belongs to the integrase inhibitor class. This overview covers key details for informational purposes only.

Vocabria (cabotegravir) is prescribed for HIV treatment in combination with other antiretrovirals. It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection in adults. This medication works by blocking integrase, an enzyme HIV needs to multiply. It is not a cure for HIV or AIDS.

Cabotegravir may cause mild to moderate injection site reactions, such as pain or swelling. Some users report fatigue, headache, or fever after administration. These effects are generally temporary and vary by individual. Always discuss persistent symptoms with a healthcare provider.

Vocabria should be stored at controlled room temperature away from moisture and heat. Keep out of reach of children and pets. Inform your healthcare provider about all medications and conditions before use. Do not use if the solution is discolored or contains particles.

Cabotegravir may interact with other medications, including certain anticonvulsants, antibiotics, and herbal supplements. Alcohol and grapefruit products may also affect its metabolism. Always review your full medication list with a healthcare professional to avoid potential interactions.